Ann: Letter to Shareholders, Notice of AGM & Proxy Form, page-123

This a serious question - are you on medication?

So DM wants his golden handshake, whislt signing off on a huge new placement to "friends" at the BOD's decretion.

Let's issue a controlling stake, at a friendly price, immediately after we get approval at the AGM.

WAKE UP, we're about to be screwed!

Again, sigh - The discussion by several posters over the resolution regarding the ability to issue an extra 10% of shares - the 7.1A Mandate clause - is a furphy. This same tactic is employed every year at AGMs by the majority of small-caps. It is wanted by BoDs for tactical purposes but is rarely utilised. There is nothing unusual about this resolution for a company of this size.

You seem very paranoid. How do we get screwed if the company sells the tech for a 'fair' price? The option conversions that have been happening in recent weeks mean that the company has lots of money, they do not need to do a CR - as DM has explicitly stated and to be honest is screamingly obvious. If you thought about that you would realise the same, unless you have another motivation for your hysterical posts i.e. wanting to push the SP down so you can buy more for less money.

This company has been a difficult one to be a shareholder in, I know that very well having initially invested in 2017 but there are plenty of SH who invested earlier than I did. Many have bailed out over the years and I don't blame them.

We are now at the end game, either the tech is ready now to be bought - if it's disruptive - or if it isn't then to me it's pretty damn close and maybe there needs to be some more work done (testing?) although personally I'm not convinced. IMEC can't do much more from an R&D perspective, they can't scale it down. So where do we go?